Jeff Fairman - 09 Dec 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
09 Dec 2021
Net transactions value
-$2,713
Form type
4
Filing time
13 Dec 2021, 16:20:36 UTC
Previous filing
28 Oct 2021
Next filing
20 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $234 +131 +2.1% $1.79* 6,291 09 Dec 2021 Direct F1
transaction PCVX Common Stock Sale $2,948 -131 -2.1% $22.50 6,160 09 Dec 2021 Direct F2
holding PCVX Common Stock 341,227 09 Dec 2021 By Fairman Family Trust
holding PCVX Common Stock 50,000 09 Dec 2021 By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -131 -0.21% $0.000000 62,714 09 Dec 2021 Common Stock 131 $1.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,016 shares acquired under the Employee Stock Purchase Plan on November 17, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The shares subject to the option are fully vested and exercisable.